Inspire Advisors LLC Acquires Shares of 7,403 GE HealthCare Technologies Inc. $GEHC

Inspire Advisors LLC acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,403 shares of the company’s stock, valued at approximately $556,000.

Other large investors have also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. grew its position in GE HealthCare Technologies by 4.2% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 159,882 shares of the company’s stock worth $11,842,000 after acquiring an additional 6,479 shares in the last quarter. Wedge Capital Management L L P NC purchased a new stake in GE HealthCare Technologies during the third quarter valued at approximately $26,859,000. Valicenti Advisory Services Inc. lifted its stake in shares of GE HealthCare Technologies by 22.6% in the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock valued at $5,115,000 after purchasing an additional 12,550 shares during the last quarter. National Bank of Canada FI boosted its holdings in shares of GE HealthCare Technologies by 133.3% in the 2nd quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock worth $66,640,000 after purchasing an additional 514,007 shares during the period. Finally, Osaic Holdings Inc. increased its position in shares of GE HealthCare Technologies by 18.1% during the 2nd quarter. Osaic Holdings Inc. now owns 224,869 shares of the company’s stock valued at $16,674,000 after purchasing an additional 34,499 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on GEHC shares. Bank of America raised their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their target price for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Finally, Evercore ISI reissued an “outperform” rating and issued a $95.00 price objective on shares of GE HealthCare Technologies in a research report on Monday, January 5th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $89.83.

GE HealthCare Technologies Price Performance

GEHC opened at $78.83 on Wednesday. The business has a fifty day moving average of $81.57 and a 200 day moving average of $77.11. The stock has a market cap of $35.91 billion, a P/E ratio of 16.29, a PEG ratio of 3.18 and a beta of 1.08. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The business had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.